Legal Representation
Attorney
Anthony E. Bennett
USPTO Deadlines
Next Deadline
In Grace Period
Section 8 (6-Year) Declaration Due (Based on registration date 2019-07-23)
Due Date
July 23, 2025
Grace Period Ends
January 23, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
38 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 20, 2025 | NA15 | E | SEC. 15 ACKNOWLEDGEMENT - E-MAILED | Loading... |
| Aug 20, 2025 | 15AK | O | REGISTERED - SEC. 15 ACKNOWLEDGED | Loading... |
| Aug 20, 2025 | NA71 | E | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | Loading... |
| Aug 20, 2025 | 71.P | O | REGISTERED - PARTIAL SEC 71 ACCEPTED | Loading... |
| Aug 11, 2025 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Jul 22, 2025 | E15R | I | TEAS SECTION 15 RECEIVED | Loading... |
| Jul 22, 2025 | ES71 | I | TEAS SECTION 71 RECEIVED | Loading... |
| Sep 16, 2024 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Sep 16, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Sep 16, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Sep 16, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Sep 16, 2024 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | Loading... |
| Sep 16, 2024 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jul 23, 2024 | REM3 | E | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | Loading... |
| Jul 13, 2024 | ADCH | M | CHANGE OF NAME/ADDRESS REC'D FROM IB | Loading... |
| Jun 15, 2024 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Nov 1, 2021 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Dec 6, 2019 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Nov 15, 2019 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Nov 15, 2019 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Oct 23, 2019 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Jul 23, 2019 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| May 7, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 7, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 17, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 16, 2019 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Mar 15, 2019 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 14, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 14, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 14, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 28, 2019 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Feb 28, 2019 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Feb 20, 2019 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Feb 19, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 15, 2019 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Feb 11, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 11, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 7, 2019 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 010
medical apparatus, instruments and devices for the cutaneous or epicutaneous administration of powdered medicated or cosmetic substances for humans or animals, namely, drug delivery patches sold without medication; occlusive dispenser for medical use sold without medication; medical instrument using electrostatic properties from a biocompatible support, namely epicutaneous patches sold without medication
Class 042
research in the field of immunotherapy; design of a scientific method for epicutaneous desensitization via immunotherapy without prior preparation of the skin other than simple and light cleaning in order to leave the cell structure of the skin intact; scientific research in the field of processing and treatment of allergies; scientific research in the field of allergy treatment for a treatment to be applied repeatedly to the skin of the patient without prior preparation of the skin, other than simple and light cleaning in order to leave the cell structure of the skin intact, thus avoiding the transfer of the allergen into the blood; drug discovery being scientific research and development of allergens; design of methods for the treatment of allergy-causing by the combination of immune cells from the skin; design of methods for treating allergies via the application of a patch to the unbroken skin of the patient without prior preparation of the skin other than simple and light cleaning in order to leave the cell structure of the skin intact
Class 044
medical services applying a method for desensitizing by immunotherapy; medical treatment of allergies, inflammatory and autoimmune diseases via allergen administration by placing a patch on the patient's intact skin while preventing the allergen from getting into the blood; medical treatment of allergies, inflammatory and autoimmune diseases using a method for desensitizing by epicutaneous immunotherapy; medical treatment of allergies, inflammatory and autoimmune diseases by epicutaneous immunotherapy without prior preparation of the skin other than simple and light cleaning in order to leave the cell structure of the skin intact; medical consultancy in the field of desensitization to combat allergies
Additional Information
Design Mark
The mark consists of the wording a "DBV TECHNOLOGIES" in black and a design comprised of two gray concentric circles above a cyan curved line. White is not claimed as a feature of the mark and represents background or transparent areas, only.
Color Claim
The color(s) gray, cyan, and black is/are claimed as a feature of the mark.
Classification
International Classes
010
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"TECHNOLOGIES"